Angle's 90%-owned portfolio company, Parsortix, which specialises in medical diagnostics, has used its cell separation device to successfully capture circulating tumour cells (CTCs) in cancer patient blood.
The Parsortix separation technology has already been used to capture cultured breast cancer cells, prostate cancer cells and lung cancer cells added to blood (spiked blood), but it is only now that the technology has been used in actual cancer patient blood.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Accelerating state pension age hikes could cost Brits in early 50s almost £18,000A recently launched review of the state pension age has sparked concern that the planned increases could be accelerated. How much could it cost you?
-
How to invest by age - the one rule everyone can followWhether you’re a seasoned investor or new to the game, here’s the one investing rule to help determine how much you should invest according to your age
